This being said, IFN-α/β secreting innate immune cells in close proximity to tumor infiltrating DCs form a pro-inflammatory niche essential for enhancing antigen processing/presentation of MHC class I/II and subsequent priming of effector T cell responses [108]. The gene discussed is IFNA1; the disease is neoplasm.